Abiopharma

FDA approve CLINDAMYCIN PHOSPHATE

FDA approve DOXYCYCLINE HYCLATE

FDA approve MACITENTAN

FDA approve CLINDAMYCIN PHOSPHATE

FDA approve LIDOCAINE HYDROCHLORIDE

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Other Scheme of Arrangement: NON-FULFILMENT OF A CONDITION OF THE EXTENSION OF TIME AND WAIVERS

ModivCare Inc (MODV) was removed from the list of traded instruments on NASDAQ exchange

Oculis to Participate in Upcoming September Investor Conferences

NASDAQ symbol attribute type Security_Name was changed. Previous value: ModivCare Inc. - Common Stock. New value: ModivCare Inc. - Common Stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: ModivCare Inc. - Common Stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: ModivCare Inc. - Common Stock.

Smith+Nephew PLC Notification

Smith+Nephew PLC Notification

QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds